About National Hospital Organization Iwakuni Clinical Center
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Bayer
2
Chugai Pharmaceutical
2
Ministry of Health, Labour and Welfare, Japan
2
Clinical Trials at National Hospital Organization Iwakuni Clinical Center
During the past decade, National Hospital Organization Iwakuni Clinical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
2021-11-17
2026-12-29
Recruiting
690
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Iwakuni Clinical Center"
#1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Mitsubishi Tanabe Pharma Corporation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at National Hospital Organization Iwakuni Clinical Center
According to Clinical.Site data, the most researched conditions in "National Hospital Organization Iwakuni Clinical Center" are
"Carcinoma, Non-Small-Cell Lung" (2 trials), "Heparin-Induced Thrombocytopenia" (2 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials) and "Extensive Disease Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "National Hospital Organization Iwakuni Clinical Center" in a lesser frequency.
Clinical Trials Intervention Types at National Hospital Organization Iwakuni Clinical Center
Most popular intervention types in "National Hospital Organization Iwakuni Clinical Center" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lazertinib" (3 trials), "Placebo" (3 trials), "Amivantamab" (2 trials), "Amivantamab Intravenous" (1 trials) and "Amivantamab Subcutaneous and Co-Formulated with Recombinant Human Hyaluronidase (SC CF)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at National Hospital Organization Iwakuni Clinical Center
The vast majority of trials in "National Hospital Organization Iwakuni Clinical Center" are
9 trials for "All" genders.
Clinical Trials Status at National Hospital Organization Iwakuni Clinical Center
Currently, there are NaN active trials in "National Hospital Organization Iwakuni Clinical Center".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in National Hospital Organization Iwakuni Clinical Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Iwakuni Clinical Center, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".